Literature DB >> 31180272

3D printing in the design of pharmaceutical dosage forms.

E B Souto1,2, J C Campos1, S C Filho1, M C Teixeira1, C Martins-Gomes3,4, A Zielinska1, C Carbone1,5, A M Silva3,4.   

Abstract

Three-dimensional (3D) printing technologies are manufacturing approaches with widespread use in industry (e.g. automotive, automobile, pharmaceutical industries). With regard to its use in pharmaceutical industry, 3D printing is demonstrating to be of added value attributed to the possibility of printing tailored pharmaceutical products, namely personalized medical devices, such as implants and other dosage forms. However, with the approval of the first 3D-printed drug-product in 2015, a new perspective has arisen, i.e. the use of this technology to produce solid oral dosage forms exhibiting complex drug release profiles and allowing for individual dosing. Technological hurdles and regulatory issues still have to be overcome before this technology can truly find its place in the healthcare sector, where it can certainly contribute to a personalized and patient-centered healthcare. This manuscript offers a comprehensive analysis of the most extensively used methods of 3D printing in the pharmaceutical field, with examples of solid oral dosage forms and other medical devices currently under development or already marketed.

Entities:  

Keywords:  3D-printing; Three-dimensional printing; medical devices; pharmaceutical development; solid oral dosage forms

Mesh:

Substances:

Year:  2019        PMID: 31180272     DOI: 10.1080/10837450.2019.1630426

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  4 in total

Review 1.  Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.

Authors:  Mohammad A Azad; Deborah Olawuni; Georgia Kimbell; Abu Zayed Md Badruddoza; Md Shahadat Hossain; Tasnim Sultana
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

Review 2.  3D Printing in Solid Dosage Forms and Organ-on-Chip Applications.

Authors:  Tarek Kassem; Tanoy Sarkar; Trieu Nguyen; Dipongkor Saha; Fakhrul Ahsan
Journal:  Biosensors (Basel)       Date:  2022-03-22

3.  Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole.

Authors:  Ju-Hyun Lee; Chulhun Park; In-Ok Song; Beom-Jin Lee; Chin-Yang Kang; Jun-Bom Park
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-19

Review 4.  Hypertension management in 2030: a kaleidoscopic view.

Authors:  Spoorthy Kulkarni
Journal:  J Hum Hypertens       Date:  2020-11-02       Impact factor: 2.877

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.